Annual D&A
$13.16 M
+$492.00 K+3.88%
December 31, 2023
Summary
- As of February 7, 2025, XERS annual depreciation & amortization is $13.16 million, with the most recent change of +$492.00 thousand (+3.88%) on December 31, 2023.
- During the last 3 years, XERS annual D&A has risen by +$11.69 million (+797.07%).
- XERS annual D&A is now at all-time high.
Performance
XERS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$3.12 M
-$30.00 K-0.95%
September 30, 2024
Summary
- As of February 7, 2025, XERS quarterly depreciation & amortization is $3.12 million, with the most recent change of -$30.00 thousand (-0.95%) on September 30, 2024.
- Over the past year, XERS quarterly D&A has dropped by -$233.00 thousand (-6.94%).
- XERS quarterly D&A is now -10.82% below its all-time high of $3.50 million, reached on December 31, 2022.
Performance
XERS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$12.75 M
-$233.00 K-1.79%
September 30, 2024
Summary
- As of February 7, 2025, XERS TTM depreciation & amortization is $12.75 million, with the most recent change of -$233.00 thousand (-1.79%) on September 30, 2024.
- Over the past year, XERS TTM D&A has dropped by -$653.00 thousand (-4.87%).
- XERS TTM D&A is now -4.87% below its all-time high of $13.40 million, reached on September 30, 2023.
Performance
XERS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
XERS Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.9% | -6.9% | -4.9% |
| 3 y3 years | +797.1% | -6.9% | -4.9% |
| 5 y5 years | +4012.5% | -6.9% | -4.9% |
XERS Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +600.4% | -10.8% | +247.5% | -4.9% | +578.6% |
| 5 y | 5-year | at high | +1120.8% | -10.8% | +882.4% | -4.9% | +1082.8% |
| alltime | all time | at high | >+9999.0% | -10.8% | >+9999.0% | -4.9% | >+9999.0% |
Xeris Biopharma Holdings Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.12 M(-1.0%) | $12.75 M(-1.8%) |
| Jun 2024 | - | $3.15 M(-1.9%) | $12.98 M(-1.6%) |
| Mar 2024 | - | $3.21 M(-1.4%) | $13.19 M(+0.3%) |
| Dec 2023 | $13.16 M(+3.9%) | $3.26 M(-2.9%) | $13.16 M(-1.8%) |
| Sep 2023 | - | $3.36 M(-0.2%) | $13.40 M(+2.2%) |
| Jun 2023 | - | $3.36 M(+5.7%) | $13.12 M(+2.3%) |
| Mar 2023 | - | $3.18 M(-9.2%) | $12.82 M(+1.2%) |
| Dec 2022 | $12.67 M(+574.2%) | $3.50 M(+14.1%) | $12.67 M(+25.9%) |
| Sep 2022 | - | $3.07 M(+0.3%) | $10.06 M(+37.6%) |
| Jun 2022 | - | $3.06 M(+1.0%) | $7.32 M(+59.9%) |
| Mar 2022 | - | $3.03 M(+237.3%) | $4.57 M(+143.4%) |
| Dec 2021 | $1.88 M(+28.1%) | $899.00 K(+178.3%) | $1.88 M(+31.8%) |
| Sep 2021 | - | $323.00 K(+0.9%) | $1.43 M(-4.0%) |
| Jun 2021 | - | $320.00 K(-5.0%) | $1.49 M(+0.1%) |
| Mar 2021 | - | $337.00 K(-24.4%) | $1.48 M(+1.2%) |
| Dec 2020 | $1.47 M | $446.00 K(+16.4%) | $1.47 M(+4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $383.00 K(+20.4%) | $1.40 M(+3.2%) |
| Jun 2020 | - | $318.00 K(-0.6%) | $1.36 M(+7.4%) |
| Mar 2020 | - | $320.00 K(-15.8%) | $1.26 M(+17.3%) |
| Dec 2019 | $1.08 M(+236.9%) | $380.00 K(+12.1%) | $1.08 M(+23.6%) |
| Sep 2019 | - | $339.00 K(+50.7%) | $872.00 K(+62.1%) |
| Jun 2019 | - | $225.00 K(+67.9%) | $538.00 K(+37.6%) |
| Mar 2019 | - | $134.00 K(-23.0%) | $391.00 K(+22.2%) |
| Dec 2018 | $320.00 K(+42.2%) | $174.00 K(+3380.0%) | $320.00 K(+29.0%) |
| Sep 2018 | - | $5000.00(-93.6%) | $248.00 K(-15.9%) |
| Jun 2018 | - | $78.00 K(+23.8%) | $295.00 K(+18.0%) |
| Mar 2018 | - | $63.00 K(-38.2%) | $250.00 K(+11.1%) |
| Dec 2017 | $225.00 K(+94.0%) | $102.00 K(+96.2%) | $225.00 K(+82.9%) |
| Sep 2017 | - | $52.00 K(+57.6%) | $123.00 K(+73.2%) |
| Jun 2017 | - | $33.00 K(-13.2%) | $71.00 K(+86.8%) |
| Mar 2017 | - | $38.00 K | $38.00 K |
| Dec 2016 | $116.00 K | - | - |
FAQ
- What is Xeris Biopharma Holdings annual depreciation & amortization?
- What is the all time high annual D&A for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual D&A year-on-year change?
- What is Xeris Biopharma Holdings quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly D&A year-on-year change?
- What is Xeris Biopharma Holdings TTM depreciation & amortization?
- What is the all time high TTM D&A for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings TTM D&A year-on-year change?
What is Xeris Biopharma Holdings annual depreciation & amortization?
The current annual D&A of XERS is $13.16 M
What is the all time high annual D&A for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual depreciation & amortization is $13.16 M
What is Xeris Biopharma Holdings annual D&A year-on-year change?
Over the past year, XERS annual depreciation & amortization has changed by +$492.00 K (+3.88%)
What is Xeris Biopharma Holdings quarterly depreciation & amortization?
The current quarterly D&A of XERS is $3.12 M
What is the all time high quarterly D&A for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly depreciation & amortization is $3.50 M
What is Xeris Biopharma Holdings quarterly D&A year-on-year change?
Over the past year, XERS quarterly depreciation & amortization has changed by -$233.00 K (-6.94%)
What is Xeris Biopharma Holdings TTM depreciation & amortization?
The current TTM D&A of XERS is $12.75 M
What is the all time high TTM D&A for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high TTM depreciation & amortization is $13.40 M
What is Xeris Biopharma Holdings TTM D&A year-on-year change?
Over the past year, XERS TTM depreciation & amortization has changed by -$653.00 K (-4.87%)